Gemsenjäger E, Heitz P U, Martina B
Surgical Clinic, Neumunster Hospital, Zurich, Switzerland.
World J Surg. 1997 Jun;21(5):546-51; discussion 551-2. doi: 10.1007/pl00012284.
Over a period of 20 years 84 papillary and 82 follicular carcinomas operated on by one surgeon and examined by one pathologist were documented prospectively, treated selectively, and followed for 1 to 20 years (median 7 years). Tumors with a low risk of recurrence or incurable disease-i.e., papillary carcinoma pT1-3 N0 M0 (n = 56) and minimally invasive follicular carcinoma (n = 37)-were treated by a limited-radicality hemithyroidectomy or total thyroidectomy without radioiodine in 79 of the 93 cases (85%). No unfavorable course was observed, and only one curable recurrence (1.3%) developed contralaterally after hemithyroidectomy for papillary cancer. Of the remaining 73 patients, including 100% of those with nodal involvement, 65 (89%) underwent total thyroidectomy with radioiodine. Total thyroidectomy was achieved in 34% of the cases by completion thyroidectomy, based on definitive histologic examination. No instance of a serious, potentially incurable recurrence and no tumor-related death was observed in patients with a papillary TNM stage I+II or with a minimally invasive follicular carcinoma. Five of the patients (6%) with papillary carcinoma, all with TNM stage III or IV, and seven of the patients (8.5%) with follicular carcinoma, all grossly invasive and pT3 or pT4, had tumor-related deaths following total thyroidectomy in all and with remnant ablation in 10 cases. A potentially curable node recurrence occurred in two patients 1 and 10 years, respectively, after primary treatment. Permanent hypoparathyroidism (n = 4) (2.4%) and permanent recurrent laryngeal nerve palsy (n = 2) (1.2%) were observed only in patients with a grossly invasive follicular carcinoma and concomitant benign recurrent goiter. We conclude that (1) hemithyroidectomy or total thyroidectomy without radioiodine is adequate for papillary carcinoma pT1-3 N0 and minimally invasive follicular carcinoma; (2) there were no nodal recurrences in tumors recognized as node-negative; and (3) extracapsular excision of one or both lobes can be carried out technically with low morbidity. The study confirms the prognostic value of age-related TNM classification for papillary carcinoma; classification of follicular thyroid carcinoma as minimally invasive or grossly invasive proved to be useful.
在20年的时间里,一位外科医生实施手术并由一位病理学家检查的84例乳头状癌和82例滤泡状癌被前瞻性记录,进行了选择性治疗,并随访1至20年(中位时间7年)。复发风险低或为不可治愈疾病的肿瘤,即乳头状癌pT1 - 3 N0 M0(n = 56)和微小浸润性滤泡状癌(n = 37),93例中的79例(85%)采用了有限根治性甲状腺半叶切除术或全甲状腺切除术,未进行放射性碘治疗。未观察到不良病程,仅1例可治愈的复发(1.3%)在乳头状癌甲状腺半叶切除术后对侧发生。其余73例患者,包括所有有淋巴结受累的患者,65例(89%)接受了放射性碘全甲状腺切除术。基于明确的组织学检查,34%的病例通过甲状腺次全切除术完成了全甲状腺切除术。在乳头状TNM分期I + II期或微小浸润性滤泡状癌患者中,未观察到严重的、潜在不可治愈的复发情况,也未观察到与肿瘤相关的死亡。5例(6%)乳头状癌患者,均为TNM III期或IV期,7例(8.5%)滤泡状癌患者,均为大体浸润性且pT3或pT4,在全甲状腺切除术后全部死亡,10例进行了残余甲状腺消融。在初次治疗后,分别有2例患者在1年和10年出现了可能治愈的淋巴结复发。仅在大体浸润性滤泡状癌合并良性复发性甲状腺肿的患者中观察到永久性甲状旁腺功能减退(n = 4)(2.4%)和永久性喉返神经麻痹(n = 2)(1.2%)。我们得出结论:(1)对于乳头状癌pT1 - 3 N0和微小浸润性滤泡状癌,甲状腺半叶切除术或无放射性碘的全甲状腺切除术是足够的;(2)被认定为淋巴结阴性的肿瘤未出现淋巴结复发;(3)技术上可以进行一侧或双侧叶的包膜外切除,并发症发生率低。该研究证实了年龄相关的TNM分类对乳头状癌的预后价值;将滤泡状甲状腺癌分类为微小浸润性或大体浸润性被证明是有用的。